Eli Lilly inks another radiopharma deal, gaining option to buy startup

Jul 1, 2024 · Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 …

CouponFollow Extension

$1
OFF

Eli Lilly Inks Another Radiopharma Deal, Gaining Option To Buy Startup

4 weeks from now

biopharmadive.com

$140
OFF

Eli Lilly Continues Radiopharma Push With $140m Radionetics …

4 weeks from now

Jul 2, 2024 · Eli Lilly has partnered with Radionetics Oncology in a $140m deal, as the drugmaker aims to get a leg up in the burgeoning radiopharmaceuticals arena.

pharmaceutical-technology.com

$140
OFF

Lilly Inks Radiopharma Deal With Radionetics, Secures Right To Buy ...

4 weeks from now

Jul 2, 2024 · Eli Lilly is expanding its radiopharmaceutical portfolio with a $140 million upfront payment to Radionetics Oncology and the exclusive future right to acquire the biotech for $1 …

biospace.com

$140
OFF

Eli Lilly And Radionetics Oncology Enter $140m Radiopharma …

4 weeks from now

Jul 2, 2024 · Lilly also entered into a strategic multi-target discovery collaboration agreement with Aktis Oncology in May to develop novel anticancer radiopharmaceuticals. Under the …

pmlive.com

$1
OFF

Lilly Inks Potential $1.1B Radiopharma Deal With Aktis Oncology

4 weeks from now

May 21, 2024 · Lilly is also making an undisclosed equity investment in Aktis. The deal builds on previous investments in radiopharma. Lilly dropped $1.4 billion to acquire Point Biopharma in …

biospace.com

$1
OFF

Lilly Signs Radiopharma Deal With Radionetics, Secures Option To Buy

4 weeks from now

Jul 2, 2024 · In May, Lilly signed a potential $1.1.6 billion deal with Boston-based biotech Aktis Oncology to develop innovative anticancer radiopharmaceuticals using Aktis’ proprietary …

pharmamanufacturing.com

$1
OFF

Eli Lilly Inks Another Radiopharma Deal, Gaining Option To Buy …

4 weeks from now

sdbn.org

$1.16
OFF

Lilly Inks Potential $1.16B Deal With Radiopharma Startup

4 weeks from now

May 21, 2024 · Eli Lilly has partnered with Boston-based biotech Aktis Oncology to develop innovative anticancer radiopharmaceuticals using Aktis’ proprietary miniprotein discovery …

pharmamanufacturing.com

$1
OFF

Eli Lilly Jumps Into Radiopharmaceuticals Via $1.4B Point …

4 weeks from now

Oct 3, 2023 · Eli Lilly’s scope in cancer is expanding to radiopharmaceuticals with the $1.4 billion acquisition of Point Biopharma Global, a company in late-stage clinical development with two …

medcitynews.com

$1
OFF

Eli Lilly Inks Radiopharma Deal Worth Up To $1.1B With Aktis - MSN

4 weeks from now

P rivately held biotech Aktis Oncology announced Tuesday a collaboration agreement with Eli Lilly (NYSE: LLY) to develop cancer-targeting radiopharmaceutical drugs in a deal worth up to …

msn.com

$60
OFF

Lilly Pays Aktis $60M To Further Dial Into Radiopharma Signal

4 weeks from now

May 21, 2024 · Eli Lilly is continuing to ride the radiopharma wave, paying Aktis Oncology $60 million upfront to work on therapeutic and diagnostic products against multiple targets. Lilly …

fiercebiotech.com

$1
OFF

Lilly To Enter Radiopharmaceutical Drug Field With $1.4B Point Buyout

4 weeks from now

Oct 3, 2023 · Eli Lilly is making a bet on radiopharmaceutical drugs for cancer, announcing Tuesday a deal to buy Point Biopharma and its pipeline of experimental therapies for …

biopharmadive.com

$1
OFF

How Novartis Is Disrupting Lilly's $1.4B Radiotherapy Plan - Fierce …

4 weeks from now

Dec 5, 2023 · On Oct. 3, Eli Lilly unveiled a $1.4 billion agreement to acquire cross-town radiopharmaceutical company Point Biopharma Global to beef up its oncology capabilities. …

fiercebiotech.com

FAQs about Eli Lilly inks another radiopharma deal, gaining option to buy startup Coupon?

Will Eli Lilly buy radionetics oncology?

Scott Olson via Getty Images Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 billion. Lilly will pay Radionetics $140 million upfront for the option rights under the deal, which the companies announced Monday. ...

Will Lilly buy radionetics?

Radionetics will continue to build its radiopharmaceutical drug pipeline through an “exercise period,” after which Lilly can choose whether to acquire the company. Radionetics is developing small molecule radiopharmaceuticals that can target G protein-coupled receptors, a ubiquitous family of proteins that present many attractive disease targets. ...

How much will Lilly pay radionetics?

Lilly will pay Radionetics $140 million upfront for the option rights under the deal, which the companies announced Monday. Radionetics will continue to build its radiopharmaceutical drug pipeline through an “exercise period,” after which Lilly can choose whether to acquire the company. ...

Does Eli Lilly own aktis oncology?

Eli Lilly inks radiopharma deal worth up to $1.1B with Aktis 22h Privately held biotech Aktis Oncology announced Tuesday a collaboration agreement with Eli Lilly (NYSE:LLY) to develop cancer-targeting radiopharmaceutical drugs in a deal worth up to $1.1B in terms of milestone payments alone. ...

Why is Lilly partnering with a pharma company to develop radiopharma?

Recent improvements in manufacturing and supplying the complex treatments have boosted investment in the field, drawing interest from large pharma companies like Lilly as well as new drug startups. The Point deal appears to be part of a broader plan by Lilly to build a presence in radiopharma drug development. ...

Where is Eli Lilly headquartered 2024?

A sign bearing Eli Lilly’s logo sits outside of the company’s headquarters on March 17, 2024 in Indianapolis, Indiana. Scott Olson via Getty Images Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 billion. ...